Background: Herbal preparations are widely assumed to be safe on oral administration and therefore the documentation of the toxic potential of some herbal concoctions used as medicine and nutrients is limited. Moringa oleifera (MO) is a plant that is gaining tremendous popularity in rural communities in Kenya as a means of offsetting nutritional and medicinal needs. However, very little is known about the safety of the plant on oral administration. Thus, the aim of the current study was to assess the biochemical and histological changes in the liver following the administration of an aqueous-methanolic (AQ-ME) MO leaf extract in female Wistar albino rats. Methods: Acute oral toxicity study on the AQ-ME MO leaf extract was conducted by the use of the limit test dose of the up and down procedure (OECD guideline number 425) with slight modifications. Briefly, ten (10) healthy, nulliparous, non-pregnant female Wistar strain albino rats aged 8-12 weeks and weighing 180±20 grams were used for the study. These animals were randomly selected into two groups; control and treatment group each having five (5) animals. They were then labelled to enable identification and control group animals were orally administered with physiological buffer saline once daily over a 48-hour period. The five (5) rats in the treatment group were dosed orally one at a time and once daily with a 2000 mg/kg dose of the AQ-ME MO leaf extract to determine the median lethal dose over a 48 hour period. Blood was then collected and used to prepare serum for biochemical analysis of aspartate amino transferase (AST), alanine amino transferase (ALT) and total bilirubin (TB) which are important biomarkers of liver dysfunction. Biochemical assays of these enzymes were performed using the method of the International Federation of Clinical Chemists (IFCC). Death was used as an endpoint, livers harvested and used to prepare transverse sections for histopathological examination. These sections were stained using the haematoxylin and eosin (H&E) method and observed for pathological changes using an optical microscope. Results: A 2000 mg/kg oral dose of AQ-ME MO leaf extract caused a significant (p<0.05) increase in the mean levels of AST but a non-significant (p>0.05) increase in the mean levels of total bilirubin in the treatment group relative to the control group. On the other hand, the extract caused a nonsignificant (p>0.05) decrease in the mean levels of ALT in the treatment group relative to the control. The post mortem analysis of the hepatic index (liver to body weight ratio) revealed that there was a non-significant increase (p>0.05) in the hepatic index of the treatment group relative to the control. However, the transverse liver sections of treatment group animals showed mild distortions in the architecture of liver cells. Conclusions: Based on these results, the LD 50 of the AQ-ME MO leaf extract was found to be >2000 mg/kg in female wistar albino rats.
INTRODUCTION
Plant resources have for a good long time sustained both human and animal life. 1 Thus, in as much as there has been an evolution in modern medicine, herbal remedies are still popular as a means of promoting healthy outcomes and mitigating disease conditions. However, there is low interest in the toxic manifestations brought about by natural products due to the unfounded belief that drugs obtained from nature are devoid of any toxic ramifications. 2 Moringa oleifera is a plant that originates in Asia but is nowadays cultivated extensively in various parts of the world. Thus, the plant goes by many names; benzolive tree, morunga, drumstick tree, nebeday among others. 3 Traditional folklore, oral history and native materia medica have associated Moringa oleifera with a range of medicinal, nutritional and miscellaneous applications. 4 Medicinally, the antioxidant, wound healing, hypotensive, and diuretic effects of this plant have been reported. [5] [6] [7] Nutritionally, the plant has been reported to be rich in calcium which boosts milk production in lactating mothers. 8 Water clarification has been reported as a miscellaneous use. 9 However, before fully embracing this plant, there is an overwhelming need to not only scientifically assess these claims but to also investigate the safety of this plant on oral administration. The rat animal model is one of the most widely used methods of evaluating acute oral toxicity effects of various substances. However, due to animal welfare reasons, methodologies using minimum number of animals are now being adopted. 10 These methods are simple, reproducible and are able to classify test substances in a similar manner to other methodologies of testing acute toxicity. The aim of the present investigation was to evaluate the potential of leaves of Moringa oleifera to cause acute oral toxicity in female wistar strain albino rats by using biochemical and histopathologic biomarkers of liver injury.
METHODS

Collection and authentication of plant material
Fresh aerial plant material of Moringa oleifera was collected from the University of Nairobi Kibwezi farm in Makueni County. The leaves were manually separated from the plant and soaked in 1% w/v sodium chloride (NaCl) for 5 minutes to remove microbes. Further washing was done with aqueous-ethanol and later the leaves were rinsed using distilled water. They were then exposed to ambient air to allow surface moisture to dry. The botanical identity was authenticated at the National Museum Herbarium, Nairobi Kenya and a voucher specimen was submitted for future reference.
Preparation of plant material
The leaves were thinly spread on a mesh tied on racks in a well-ventilated, insect, rodent and dust free room. They were allowed to dry in the shade for 10 days. The dried leaves were reduced to powder using an electric mill at the Department of Public Health, Pharmacology and Toxicology of the University of Nairobi.
Preparation of the extract from the plant material
In preparing the extract, the method of Anwar et al was adopted with slight modifications. 11 One hundred grams of dried leaf powder of Moringa oleifera was accurately weighed on an analytical balance (Mettler PM 4600) and poured into a one liter conical flask wrapped in aluminium foil. Eight hundred ml of a methanol-water co-solvent system in the ratio 80:20 v/v was then gradually added to the powder with gentle agitation until slurry of uniform consistency was formed. The phytochemicals present in the leaf powder were then extracted by stirring technique using a magnetic bar and stirrer (Heidolph, Germany). The stirrer was set to operate at 200 revolutions per minute for 48 hours and this process was repeated for another batch of 100 grams of leaf powder. The slurry was then centrifuged (Heraeus technik centrifuge, Germany) at 3000 revolutions per minute (RPM) for 5 minutes and the supernatant collected and subsequently transferred to a rotary evaporator (Búchi-technik AG, Switzerland) set at 45°C to remove excess solvent and concentrate the extract. Further solvent removal and concentration of the extract was done in a sand bath for 24 hours. The dark brown semi-solid product was then stored in light resistant bottles and later refrigerated awaiting further work.
Animal model
Ten healthy female wistar strain albino rats aged between 8 and 12 weeks and weighing 180±20 grams were used for the study. The animals used were nulliparous and non-pregnant. They were obtained from the animal house of the Department of Public Health, Pharmacology and Toxicology of the University of Nairobi. Before commencement of the study, ethical approval was obtained from the Faculty of Veterinary Medicine Biosafety, Animal Care and Use Committee (BACUC) of the University of Nairobi. Reference BACUC/J56/76385/2014 issued on 20-01-2016.
Housing and feeding conditions
Rat cages measuring 35 (L) ×25 (W) ×18 (H) were used to house the animals. The cages were lined with wood shavings which served as beddings for the animals. The temperature in the animal house was maintained at 25±3°C and relative humidity at 56±4%. Rat pellets from a commercial feed supplier (Unga feeds) were used to feed the animals. Water was provided ad libitum and a 12-hour light and dark cycle was maintained.
Experimental design for acute oral toxicity study
The animals were randomly assigned to two groups of 5 rats each. They were individually weighed and marked to enable identification. They were then fasted overnight before commencement of the study. Group 1 served as the control and animals in this group were orally administered with 2 ml of physiological buffer saline once daily. Group 2 served as the treatment group and a test dose (2000 mg/kg) of AQ-ME MO was selected based on the limit test dose of the up and down procedure for determining LD 50 . 12 Five female rats were orally dosed with the extract one at a time over a 48-hour period as follows; animal 1 was orally dosed with 2000 mg/kg of the extract using physiological buffer saline as vehicle. The survival of this animal dictated the sequential administration of the same dose to 4 other animals. Physical changes in the mucous membranes, appearance of the fur and skin were monitored over a 48-hours period as were clinical signs of the rate of respiration, perspiration, incidence of urinary incontinence, blood pressure changes and heart rate. Moreover, central nervous system effects such as locomotor activity, sensitivity to sound, drowsiness, tremors, convulsions were also used as indices for assessing the acute oral toxic effect of the Moringa oleifera leaf extract. The guidance document on humane endpoints was used to limit the overall suffering of the animals. 13
Handling of animals and biochemical analysis
Laboratory established protocols were followed throughout the study. 13 Latex hand gloves and protective masks were used at all times. In addition, anti-tetanus and anti-rabies vaccines were made available and stored under refrigeration. Blood was collected from each animal 48 hours after extract administration via the lateral vein of the tail using a 2 ml hypodermic syringe and needle when the animal was restrained. An aliquot (1.0 ml) of the collected blood was placed in plain tubes for biochemical analysis. This blood was left to stand for 30-45 minutes and thereafter centrifuged at 3000 revolutions per minute for 10 minutes to extract serum which was stored at -20°C and used within 12 hours for biochemical assays. Aspartate amino transferase (AST), alanine amino transferase (ALT) and total bilirubin (TB) were assayed for each animal using commercial kits according to the manufacturer's protocols. 14 Thereafter the animals were humanely euthanized using intravenous sodium pentobarbital injection (150 mg/kg bwt) and death was confirmed by using the following indicators; lack of heartbeat, lack of respiration, lack of corneal reflex, lack of response to pinch and greying of the mucous membranes. Livers were harvested and stored in 10% formalin to facilitate histopathological work.
Disposal of rodent carcasses
After confirmation of death, the carcasses were placed in special non-polyvinylchloride (non-PVC), sealable, transparent plastic bags. They were then incinerated.
Gross pathology of the rat livers
For liver histopathological analysis, mid-sections of the left lobes of the liver were collected for histopathology. The rat liver tissue specimens were fixed in 10% formalin. Once fixed, the tissues were processed and embedded in paraffin wax. The tissue blocks were sectioned at 5 microns (5µ) using a microtone. The sections were then de-paraffinized, hydrated, stained using haematoxylin and eosin (H&E) and observed under the light microscope.
Statistical analysis
Results were presented as mean±standard error of the mean and data analysed using GenStat Discovery 4 th edition statistical software. One-way analysis of variance (ANOVA) was used to analyse the data. Decision was made at significance level of 95% (p≤0.05).
RESULTS
Physico-clinical changes and mortality
The oral administration of the aqueous-methanol M. oleifera leaf extract at a dose of 2000 mg/kg over a 48-hour period (48-hr, LD 50 ) did not produce any physical changes in the skin, fur, eyes and mucous membranes. Additionally, there were no significant changes in the clinical signs of respiration and heart rate, blood pressure, salivation, lacrimation, perspiration, urinary incontinence and defecation. Moreover, the animals did not show any signs of aggression during handling. However, at the onset of test extract administration (2000 mg/kg), there was a decrease in the locomotor activity of 3 out of the 5 animals which normalised after 10 minutes. No mortality or morbidity was observed in any of the animals during the entire period of the study.
Liver weight to body weight ratio (hepatic index)
Post mortem analysis of the hepatic index (liver to body weight ratio) revealed that there was a non-significant increase (p>0.05) in the hepatic index of the treatment group relative to the control (Table 1) . 
Biochemical changes
The mean level of serum AST was significantly elevated in the treatment group (2000 mg/kg) relative to the control while there was a non-significant decrease in the level of serum ALT in the treatment group relative to the control ( Table 2) . From our observations, the AST/ALT ratio of control and treatment group (2000 mg/kg) was in the range 1.22±0.21 and 1.58±0.14 respectively. 
Histopathological changes
To further evaluate the toxic potential of the AQ-ME MO leaf extract we performed histological examinations on the rat liver sections. Histopathology of the livers from the control group showed normal regular liver architecture characterised by; normal distinct hepatocytes and scanty congestion of the hepatic vein (Figure 1) . However, histopathological work on the liver of experimental rats treated with a 2000 mg/kg dose of the AQ-ME MO leaf extract revealed a mild form of hepatic injury characterized by focal hepatocyte swelling and necrosis in areas around the central vein and hepatic veins as well as congestion of hepatic vessels (Figure 2 ). 
DISCUSSION
The findings of the present study indicate that the AQ-ME M. oleifera leaf extract showed no relevant toxic manifestations and mortality at the test dose of 2000 mg/kg. According to Husna RN et al, the absence of toxic manifestations and mortality in animals treated with a particular test dose implies that the LD 50 is greater than the test dose. 15 Although this may hold true, studies that are more elaborate and long term are essential to determine the potential toxic ramifications of this extract. [17] [18] [19] [20] Thus, the observed decrease in locomotor activity in the experimental rats treated with a 2000 mg/kg dose of the extract may be attributable to the presence of the flavonoid phytochemical.
Hepatic index is the ratio of the liver to the overall body weight. It is a more accurate means of establishing the changes in the size of the liver as compared to only measuring the weight of the liver alone because to a large extent, liver weight is dependent on experimental animal size. 21 In the present study, post mortem analysis of the hepatic index revealed that there was a non-significant increase in the hepatic index of the treatment group relative to the control. This observation is in agreement with the findings of previous authors who reported alterations in the hepatic index of animal models treated with various plant extracts. 22, 23 There was a significant elevation in AST in the treatment group relative to the control. This is suggestive of the occurrence of general cellular damage and is consistent with the observations of previous authors. 24, 25 However, since ALT is a more specific biomarker of liver injury and given the fact that AST may also be found in other tissues (cardiac, brain and skeletal muscles) these findings suggest that the aqueous-methanol M. oleifera leaf extract may not obviously cause toxic manifestations in the liver but may probably have some toxic effect on other tissues. 26 Furthermore, there was no significant difference in the levels of bilirubin between the control and treatment groups, further validating the low oral toxicity of the aqueous-methanol leaf extract at the tested dose. Bilirubin is a catabolic product of haemoglobin. Elevated levels of this substance accurately indicate the incidence of haemolysis. 27 Moreover, the AST/ALT ratio may be useful in the diagnosis of some diseases of the liver. 28 A value of less than 1 may point to the occurrence of leakage of ALT into systemic circulation while a ratio greater than 1 may be indicative of myocardial infarction. When the value is greater than 2 it may suggest alcoholic hepatitis or steatosis. 29 From our observations, the mean AST/ALT ratio of the treatment group rats was non-significantly higher than that of the control group rats. This result compares well with the work of other authors who studied the effects of these parameters post extract administration. 30 Based on the findings of histopathological work on the livers of rats treated with a 2000 mg/kg dose of AQ-ME M. oleifera leaf extract, there was indication of early signs of a mild form of liver injury implying that the extract may have some potentially deleterious effects on the liver at higher doses. This is in agreement with the work of other authors. 31 The observed effects may possibly be due to primary or secondary metabolic products of one or several of the phytochemicals present in the extract.
CONCLUSION
Thus, in view of these results, the LD 50 of the aqueousmethanol M. oleifera leaf extract was found to be >2000 mg/kg body weight in the tested animal model. However, it is evident from these results that the aqueousmethanol M. oleifera leaf extract may have some potential of causing toxic effects at higher doses in female wistar strain albino rats. There is a need for further work on the sub-acute and chronic effects of this extract.
